84547-62-6

Usage

Uses

Used in Pharmaceutical Research and Development:
(1-Methyl-1H-pyrazol-3-yl)methanol is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure and properties make it a valuable component in the development of new drugs and therapeutic agents.
Used in Chemical Synthesis:
(1-Methyl-1H-pyrazol-3-yl)methanol is used as a reagent in the synthesis of other complex organic molecules. Its versatility in forming different chemical bonds and its ability to act as a building block contribute to its utility in creating a wide range of chemical products.
Used in Material Science:
(1-Methyl-1H-pyrazol-3-yl)methanol is used as a component in the development of new materials with specific properties. Its incorporation into polymers or other materials can lead to the creation of materials with enhanced characteristics, such as improved stability or reactivity.
Used in Analytical Chemistry:
(1-Methyl-1H-pyrazol-3-yl)methanol is used as a reference compound or a standard in analytical chemistry. Its well-defined structure and properties make it suitable for use in calibration and quality control processes, ensuring the accuracy of analytical measurements.

InChI:InChI=1/C5H8N2O/c1-7-3-2-5(4-8)6-7/h2-3,8H,4H2,1H3

Upstream product

• 84547-60-4 1-methyl-1H-pyrazole-3-carbonyl chloride 
• 88529-79-7 ethyl 1-methyl-1H-pyrazole-3-carboxylate 
• 27258-32-8 1-methyl-1H-pyrazole-3-carbaldehyde 
• 100852-80-0 diethyl 1-methylpyrazole-3,5-dicarboxylate 
• 25016-20-0 1-methylpyrazole-3-carboxylic acid 
• 930-36-9 1-methyl-1H-pyrazole 
• 68-12-2 N,N-dimethyl-formamide 
• 17827-61-1 methyl ester of 1-methylpyrazole-3-carboxylic acid 

Downstream Products

• 27258-32-8 1-methyl-1H-pyrazole-3-carbaldehyde 
• 1607023-49-3 5-(4-chloro-3-(2,2,2-trifluoroethoxy)phenyl)-3-(1-methyl-1H-pyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-7(4H)-one 
• 1607023-04-0 5-(4-chloro-3-methoxyphenyl)-3-(1-methyl-1H-pyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-7(4H)-one 
• 84547-64-8 3-(chloromethyl)-1-methyl-1H-pyrazole 
• 1309208-00-1 3-({[1-benzhydrylazetidin-3-yl]oxy}methyl)-1-methyl-1H-pyrazole 
• 1191923-33-7 N-[(1S)-1-cyclohexyl-2-(methylamino)-2-oxoethyl]-5-{5-[(1-methyl-1H-pyrazol-3-yl)methoxy]pyridin-2-yl}furan-2-carboxamide 
• 84547-72-8 1-methyl-3-(p-nitrostyryl)pyrazole 
• 132668-85-0 trans, trans-1,4-bis<2-(1-methylpyrazol-3-yl)vinyl>benzene 

Relevant academic research and scientific papers

SUBSTITUTED GUANIDINE DERIVATIVE

The present invention provides a compound of general formula (I) (wherein, R1, X, p and q are as described in the present description and claims), or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing that compound.

HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK

Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.

BICYCLIC COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF

The present invention provides bicyclic beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer’s disease.

Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems. Part IV. 2-Alkyl substituents containing cationic heteroaromatics linked via a C-C bond

The synthesis and biological activity of a novel series of 2-alkyl-4-pyrrolidinylthio-β-methylcarbapenems containing a variety of cationic heteroaromatic substituents linked via a C-C bond is described. As a result of these studies, we selected FR21818 (1

Cephalosporin derivatives

Novel cephalosporin derivatives and physiologically acceptable salts thereof which are useful as antibacterial agents against gram-negative and gram-positive bacteria, and a process for preparing these compounds are disclosed.

Synthesis of Macrobicyclic Ligands containing Pyrazole Subunits: the N,N'-Bipyrazolyl Cryptand

The pyrazolyl cryptands (1) and (2) have been obtained in one-step, non high-dilution macrobicyclization reaction, from a 1,1'-bipyrazole derivative; similarly, tripodal ligands (7)-(9) with pyrazole structures are described.